Vyvanse 40 MG capsule 100S
Ended Awarded
- Contract number
- SPE2DB25FBVVS
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,644
Award facts
- Contract value 100% obligated
- $1,644.49 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $1,644.49 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 40 mg, a prescription stimulant medication commonly used to treat attention deficit hyperactivity disorder. The contract, awarded on April 23, 2025, with an ultimate completion date of April 24, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). This prime IDC, valued at $999,999,999.00 and extending through December 2026, serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply medications and medical supplies to military healthcare programs worldwide. The award involved no set-aside designation and was competitively awarded, with performance to occur at AmerisourceBergen's Conshohocken, Pennsylvania facility.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's contract portfolio with DLA demonstrates extensive capability in delivering both brand-name and generic pharmaceuticals, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. This delivery order exemplifies the company's role as a critical vendor within the military healthcare supply chain, fulfilling individual medication requirements through the established IDC framework that provides operational flexibility for military medical support.
Quick answers
Who was awarded contract SPE2DB25FBVVS?
SPE2DB25FBVVS was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on April 23, 2025.
How much is contract SPE2DB25FBVVS worth?
The government has obligated $1,644 on SPE2DB25FBVVS.
Is contract SPE2DB25FBVVS an order under another contract?
Yes. SPE2DB25FBVVS is a delivery order under SPE2DB24D2012, an indefinite delivery contract.
Was contract SPE2DB25FBVVS competed?
The extent of competition for SPE2DB25FBVVS was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award